GI ASC market not deterred by COVID-19, could hit $10.27B by 2027

The U.S. gastroenterology ASC market was worth $7.21 billion in 2019 and is expected to grow at a compound annual growth rate of 5.8 percent through 2027 to hit $10.27 billion, according to a Reports Globe report.

Advertisement
By: Staff

Leading companies in the market include:

  • Olympus
  • Johnson & Johnson
  • Medtronic
  • GE Healthcare
  • Boston Scientific
  • Cardinal Health

The majority of centers are either affiliated with a hospital, freestanding or physician-owned.

More articles on surgery centers:
3 ASC developments worth over $10M
7 critical steps for financial success in your ASC
10 most common procedures in ASCs

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

How 7 health systems are driving measurable gains in capacity and throughput

Recommended Whitepaper

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.